Symposium was hosted January 10 – 13, 2022, with over 4,000 registrants from 82 countries. This four-day virtual event featured 31 oral presentations and 37 scientific posters from genomic scientists at leading institutions, who reported their use of OGM and its utility for genetic disease and cancer applications. Each day focused on four key clinical areas: constitutional cytogenomics, hematologic malignancies, solid tumors, and OGM + NGS.

If you missed the live event, it’s not too late! On-demand presentations are available with free registration at https://www.labroots.com/ms/virtual-event/bngo2022.